Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC) Meeting Abstract
| Authors: | O'Reilly, E. M.; Smith, L. S.; Bendell, J. C.; Strickler, J. H.; Zalupski, M.; Gluck, W.; Kapoun, A.; Yen, W. C.; Xu, L.; Hill, D.; Zhou, L.; Dupont, J.; Cohn, A. L. |
| Abstract Title: | Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC) |
| Meeting Title: | 2015 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2015 Jan 15-17 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-01-20 |
| Language: | English |
| ACCESSION: | WOS:000356883800276 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.3_suppl.278 |
| Notes: | Meeting Abstract: 278 -- Source: Wos |
